First Trust Capital Management’s Tourmaline Bio TRML Stock Holding History

First Trust Capital Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-695,757	Closed	-$33.3M	–	179
2025 Q3	$33.3M	Buy	+695,757	New	+$19.3M	2.15%	10

First Trust Capital Management's TRML Position: Q4 2025 in Review

First Trust Capital Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 695,757 shares — an estimated $33.3M sold.

First Trust Capital Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $33.3M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

First Trust Capital Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
First Trust Capital Management sold 695,757 Tourmaline Bio shares in Q4 2025, an estimated $33.3M.
First Trust Capital Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
First Trust Capital Management's Tourmaline Bio position peaked at $33.3M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on First Trust Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.